2020
DOI: 10.1101/2020.04.13.039438
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

A Live Attenuated Vaccine Model Confers Cross-Protective Immunity Against Different Species ofLeptospiraspp.

Abstract: 26

Help me understand this report
View published versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

1
7
0

Year Published

2020
2020
2022
2022

Publication Types

Select...
3
1

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(8 citation statements)
references
References 54 publications
1
7
0
Order By: Relevance
“…Another attenuated Copenhageni mutant, fcpA , is a motility-deficient mutant lacking the expression of a flagellar protein, FcpA [ 48 ]. Both have been used as cross-protective vaccines [ 44 , 49 ]. Single infection with either mutant protected mice and hamsters against homologous and heterologous challenges and reduced renal colonization [ 44 , 49 ].…”
Section: Introductionmentioning
confidence: 99%
See 2 more Smart Citations
“…Another attenuated Copenhageni mutant, fcpA , is a motility-deficient mutant lacking the expression of a flagellar protein, FcpA [ 48 ]. Both have been used as cross-protective vaccines [ 44 , 49 ]. Single infection with either mutant protected mice and hamsters against homologous and heterologous challenges and reduced renal colonization [ 44 , 49 ].…”
Section: Introductionmentioning
confidence: 99%
“…Both have been used as cross-protective vaccines [ 44 , 49 ]. Single infection with either mutant protected mice and hamsters against homologous and heterologous challenges and reduced renal colonization [ 44 , 49 ]. Interestingly, it has been recently shown that the attenuated fcp1/fcpA mutant conferred cross-protection through anti- Leptospira antibodies directed against proteins, but not through agglutinating antibodies.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Another attenuated Copenhageni mutant, fcpA , is a motility-deficient mutant lacking the expression of a flagellar protein, FcpA (48). Both have been used as cross-protective vaccines (44, 49). Single infection with either mutant protected mice and hamsters against homologous and heterologous challenges and reduced renal colonization (44, 49).…”
Section: Introductionmentioning
confidence: 99%
“…Both have been used as cross-protective vaccines (44, 49). Single infection with either mutant protected mice and hamsters against homologous and heterologous challenges and reduced renal colonization (44, 49). This protection has been shown to be conferred by antibodies, although, this has not been investigated in detail.…”
Section: Introductionmentioning
confidence: 99%